Jong-Gu Choi

Jong-Gu Choi

Auto-generated profile, based on publicly available information

Jong-Gu Choi

Department of Digital Healthcare Engineering, College of Health Sciences, Sangji University 1 , Wonju 26339, South Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in Advanced Science
Verified
Journal Article
Open access
MHMahbub Hasan
Mahbub Hasan
JCJong‐Gu Choi
Jong‐Gu Choi
HAHafeza Akter
Hafeza Akter
HKHasung Kang
Hasung Kang
MAMeejung Ahn
Meejung Ahn
SLSang-Suk Lee
Sang-Suk Lee
Tolerance induction is critical for mitigating T cell‐mediated inflammation. Treatments based on anti‐CD3 monoclonal antibody (mAb) play a pivotal role in inducing such tolerance. Anti‐CD3 mAb conjugated with dextran‐coated magnetic nanoparticles (MNPs) may induce inflammatory tolerance is posited. MNPs conjugated with anti‐CD3 mAb (Ab‐MNPs) are characterized using transmission and scanning electron microscopy, and their distribution is assessed using a nanoparticle tracking analyzer. Compared to MNPs, 90% of Ab‐MNPs increased in size from 54.7 ± 0.5 to 71.7 ± 2.7 nm. The in vitro and in vivo studies confirmed the therapeutic material as nontoxic and biocompatible. Mice are administered various dosages of Ab‐MNPs before receiving concanavalin‐A (ConA), an inflammation inducer. Preadministration of Ab‐MNPs, as opposed to MNPs or anti‐CD3 mAb alone, significantly reduced the serum levels of interferon‐γ and interleukin‐6 in ConA‐treated mice. Additionally, the transdermal stamp patch as an effective delivery system for Ab‐MNPs is validated. This study demonstrates the utility of the Ab‐MNP complex in pathologies associated with T cell‐mediated hyperinflammation, such as organ transplantation and COVID‐19.

1 February 2023 in AIP Advances
Verified
Journal Article
Open access
PDF file
MHMahbub Hasan
Mahbub Hasan
JCJong-Gu Choi
Jong-Gu Choi
HAHafeza Akter
Hafeza Akter
SLSang-Suk Lee
Sang-Suk Lee
Cytokine storm is characterized by increased levels of proinflammatory cytokines. Magnetic nanoparticles (MNPs)-conjugated antibody therapy is promising in treating cytokine storms. This study will evaluate the time-dependent distribution of the silica-coated MNP (MNP-Si) in the spleen and consequent serum cytokine changes for 30 days. MNP-Si were administered to female BALB/c mice via the tail vein injection. The distribution of Fe in the spleen tissue was analyzed by ICP-MS both in control and MNP-Si-treated mice. Moreover, the acute immune toxicity in serum was investigated by analyzing IFN-γ and IL-6 levels. Fe in the control spleen is 0.98 × 106 μg/mg of dry weight. The highest average concentration of Fe in the spleen was measured on day 10 (1.4 × 106 μg/mg). And at day 30, Fe levels decreased to 1.0 × 106 μg/mg. IFN-γ levels significantly increase to a maximum on day 6 and remain elevated until day 30. IL-6 levels are not elevated after MNP-Si administration. Although the cytokines in tissue homogenates were elevated at day 20, the data are statistically non-significant. In conclusion, the proinflammatory cytokine IFN-γ levels were increased on day 6, indicating induced activation of macrophages and systemic inflammation after MNP-Si administration. Therefore, the dose and composition of the MNP-Si should be revised for potential usage for therapeutic purposes.

1 February 2024 in AIP Advances
Verified
Journal Article
Open access
PDF file
SLSang-Suk Lee
Sang-Suk Lee
RCRak-Gun Choi
Rak-Gun Choi
WKWon-Tae Kim
Won-Tae Kim
MSMyung-Woo Shin
Myung-Woo Shin
JCJong-Gu Choi
Jong-Gu Choi
BJByungjo Jung
Byungjo Jung
The Hall element and optical sensor, which can detect the magnetic field change caused by the minute fluctuations of the permanent magnet according to the periodic movement of the radial artery and the light absorption and reflection intensity according to the change in wrist blood flow, respectively, are used as key elements in digital healthcare devices. The pulse waves of the radial artery inside the wrist were measured and analyzed using a clip-type pulsimeter, magnetoplethysmogram (MPG). The pulse wave, which is the change in blood flow obtained by photoplethysmogram (PPG), was measured on the dorsal side of the wrist or the fingers simultaneously with MPG. The ABFV (artery blood flow velocity) is a few ten cm/s as DH (distance between MPG and PPG) divided by ΔT(a) which is the time difference between the first peaks of MPG and PPG waveforms on the dorsal side of the wrist. The PBFV (peripheral blood flow velocity) is a few mm/s as LH (hand length) divided by ΔT(p), which is the time difference between the first peak of MPG waveform and the third peak PPG waveform on the finger. For four subjects of 20s, SPWV was approximately 0.98∼1.19 m/s, ABFV in the radial artery was approximately 0.40∼0.44 m/s, and finger capillary PBFV was approximately 6.3∼8.6 cm/s. These results show reasonable values similar to the blood velocity of many blood vessels flowing through the human body.

28 February 2022 in Journal of Acupuncture and Meridian Studies
Verified
Journal Article
Open access
PDF file
SCSang-Heon Choi
Sang-Heon Choi
JCJong-Gu Choi
Jong-Gu Choi
SLSang-Suk Lee
Sang-Suk Lee
Sang-Heon Choi, Jong-Gu Choi, Sang-Suk Lee. J Acupunct Meridian Stud 2022;15:37-42. https://doi.org/10.51507/j.jams.2022.15.1.37

1 January 2024 in AIP Advances
Verified
Journal Article
Open access
PDF file
JCJong-Gu Choi
Jong-Gu Choi
MHMahbub Hasan
Mahbub Hasan
SLSang-Suk Lee
Sang-Suk Lee
Iron oxide nanoparticles (NPs) are biocompatible, have excellent magnetic properties, respond to external magnetic fields, and have been used in many studies on drug delivery systems. In this study, hyaluronic acid (HA)–superparamagnetic microneedles containing superparamagnetic iron oxide nanoparticles were manufactured using HA as the matrix material. Optical and scanning electron microscopy (SEM) were used to investigate the characteristics of the magnetized microneedles (MMNs). The mechanical rigidity of MMNs for in vivo evaluation is expected to be sufficient, as evidenced by a transmittance greater than 90%. Additionally, the superconducting quantum interference device-vibrating sample magnetometer measurement results confirmed that the magnetic characteristics did not change, even after the magnetic nanoparticles (MNPs) were manufactured. The hysteresis curves of the NPs confirmed the maintenance of the magnetic properties, including a coercivity of 60 Oe and susceptibility of 4 × 10-6 emu/gOe. Based on these results, MNPs are expected to be useful as a delivery material for transdermal drug delivery systems, magnetic resonance imaging, and molecular imaging.

1 January 2024 in AIP Advances
Verified
Journal Article
Open access
PDF file
MHMahbub Hasan
Mahbub Hasan
JCJong-Gu Choi
Jong-Gu Choi
SLSang-Suk Lee
Sang-Suk Lee
Drug distribution is a vital parameter for depicting the pharmacokinetic properties of therapeutic agents. Magnetic nanoparticles (MNPs) conjugated with anti-cluster of differentiation 3 (anti-CD3) monoclonal antibody (MNPs-Ab) is a promising immunotherapeutic agent. Magnet-guided targeted delivery of MNPs has been studied exclusively in oncology. The distribution of MNPs is routinely analyzed by measuring Fe levels using inductively coupled mass spectrometry (ICP-MS). However, the ICP-based methods measure the total iron content, including endogenous iron. We used an efficient approach that measured MNPs-Ab distribution after intravenous administration using an in vivo imaging system. The fluorescent-labeled anti-CD3s are conjugated with dextran-coated magnetic nanoparticles (50 nm diameter) by the glutaraldehyde conjugation method. MNPs-Ab was intravenously administered to BALB/c mice. The fluorescence intensity in live animal and organs were analyzed after 0, 1, and 24 h. The conjugation of fluorescently labeled antibodies with MNPs was validated. The attachment of a permanent magnet on the dorsal skin area successfully guided the intravenously injected Ab-MNPs within 24 h. However, after 1 h, no observable fluorescence was seen at the target site. The in vitro organ distribution study confirms nanoparticles’ predominant distribution in the liver and kidneys-the intensities of the fluorescence increase after 24 h than 1 h. Our in vivo imaging studies confirmed the external magnet-driven targeted distribution of the antibody-conjugated nanoparticle. Besides, the in vivo imaging system enables rapidly identifying the distributed nanoparticles.